Industry News
Pharmaceutical Industry News
AAN: AstraZeneca touts new Ultomiris gMG data ahead of potential Argenx showdown
AAN: AstraZeneca touts new Ultomiris gMG data ahead of potential Argenx showdown kdunleavy Wed, 04/06/2022 - 11:11
Amgen gives CEO a pay bump despite its eventful year ending in stagnant revenue
Amgen gives CEO a pay bump despite its eventful year ending in stagnant revenue aliu Wed, 04/06/2022 - 09:52
Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyout
Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyout esagonowsky Wed, 04/06/2022 - 09:50
Novartis scores accelerated FDA nod for Vijoice to treat rare overgrowth condition
Novartis scores accelerated FDA nod for Vijoice to treat rare overgrowth condition kdunleavy Wed, 04/06/2022 - 09:24
In India, Parents of Children with Rare Disease Plea for Help Online
India makes many of the world’s drugs, but treatments for rare diseases like spinal muscular atrophy are imported and prohibitively costly. In desperation, parents are raising funds on social media.
Folx Health doubles down on LGBT+ fund, focuses on Black trans community
Folx Health doubles down on LGBT+ fund, focuses on Black trans community sharon.coey Wed, 04/06/2022 - 07:59
Salix: Half of IBS, chronic constipation patients lately find their condition ‘more challenging to manage’
Salix: Half of IBS, chronic constipation patients lately find their condition ‘more challenging to manage’ badams Wed, 04/06/2022 - 07:22
Could text messages nudge people toward COVID vaccines? Not here, but it might be bad timing
Could text messages nudge people toward COVID vaccines? Not here, but it might be bad timing badams Wed, 04/06/2022 - 04:48
The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.
Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2.
GSK, Vir’s COVID antibody put on ice as BA.2 subvariant takes hold
GSK, Vir's COVID antibody put on ice as BA.2 subvariant takes hold esagonowsky Tue, 04/05/2022 - 15:30
BioNTech CEO’s pay fell last year, but he’s still a billionaire thanks to holdings in mRNA specialist
BioNTech CEO's pay fell last year, but he's still a billionaire thanks to holdings in mRNA specialist aliu Tue, 04/05/2022 - 11:24
Merck, during a transition year, doled out nearly $30M to its pair of CEOs
Merck, during a transition year, doled out nearly $30M to its pair of CEOs kdunleavy Tue, 04/05/2022 - 11:15
GAO confirms questionable Trump-era celeb campaign ad spend
GAO confirms questionable Trump-era celeb campaign ad spend nmissakian Tue, 04/05/2022 - 11:08
Jardiance sparks Boehringer Ingelheim’s 2021 growth, with more likely on the way
Jardiance sparks Boehringer Ingelheim's 2021 growth, with more likely on the way kdunleavy Tue, 04/05/2022 - 09:21
How did Merck record an 11% tax rate last year? The Senate finance chairman would like to know
How did Merck record an 11% tax rate last year? The Senate finance chairman would like to know esagonowsky Tue, 04/05/2022 - 09:19
Bluebird bio cuts 30% of its workforce as gene therapy dreams dashed in Europe, delayed in US
Bluebird bio cuts 30% of its workforce as gene therapy dreams dashed in Europe, delayed in US aliu Tue, 04/05/2022 - 09:03
Novartis gets FDA nod to begin making Zolgensma in North Carolina
Novartis gets FDA nod to begin making Zolgensma in North Carolina jkeenan Tue, 04/05/2022 - 08:51
Genprex pairs gene therapy delivery tech with Keytruda in lung cancer trial
Genprex pairs gene therapy delivery tech with Keytruda in lung cancer trial ntaylor Tue, 04/05/2022 - 08:45
Physician poll finds ultralong-acting regimens and home administration could transform HIV market
Physician poll finds ultralong-acting regimens and home administration could transform HIV market ntaylor Tue, 04/05/2022 - 06:38
Oral prolonged-release ketamine advances after COVID-disrupted trial
Oral prolonged-release ketamine advances after COVID-disrupted trial ntaylor Tue, 04/05/2022 - 06:33